Cargando…
HRSV prefusion-F protein with Adju-Phos adjuvant induces long-lasting Th2-biased immunity in mice
The development of human respiratory syncytial virus (hRSV) vaccine has been hampered by the risk of enhanced respiratory disease (ERD) which was induced by highly skewed toward Th2 immune response. In our previous study, we expressed the recombinant pre-F protein using Escherichia coli BL21, called...
Autores principales: | Li, Hai, Ren, Hu, Zhou, Yangzi, Zhang, Yan, Cao, Lei, Xu, Wenbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803181/ https://www.ncbi.nlm.nih.gov/pubmed/35100303 http://dx.doi.org/10.1371/journal.pone.0262231 |
Ejemplares similares
-
Adenovector 26 encoded prefusion conformation stabilized RSV-F protein induces long-lasting Th1-biased immunity in neonatal mice
por: van der Fits, Leslie, et al.
Publicado: (2020) -
Establishment and application of a lethal model of an HRSV-long variant strain in BALB/c mice
por: LI, Hai, et al.
Publicado: (2022) -
Intranasal vaccination with a recombinant protein CTA1-DD-RBF protects mice against hRSV infection
por: Li, Hai, et al.
Publicado: (2021) -
Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines
por: Isaacs, Ariel, et al.
Publicado: (2021) -
Immunogenicity of an AS01-adjuvanted respiratory syncytial virus prefusion F (RSVPreF3) vaccine in animal models
por: Bouzya, Badiaa, et al.
Publicado: (2023)